George Theodore

Clinical Insight

Navigating Polypharmacy: How Genetic Testing Can De-Risk Prescribing for Patients on Multiple Medications

For any clinician managing patients with co-morbid conditions, polypharmacy is the norm. It’s a delicate balancing act of therapeutic goals, but each new prescription added to the regimen increases the risk of a cascade of negative outcomes: drug-drug interactions, adverse drug reactions (ADRs), and therapeutic failures. Standard interaction checkers are a valuable first line of defense, but they are missing a critical piece of the puzzle: the patient’s unique genetic blueprint. Pharmacogenetic

Read

Clinical Insight

Poor Metabolizer vs. Ultra-Rapid: A Clinician's Guide to PGx-Informed Dosing Strategies

The clinical mantra of "start low, go slow" has long guided prescribing, but it's an approach born from necessity, not precision. It’s a tacit acknowledgment that patients metabolize medications at vastly different rates. What if you could know a patient's metabolic capacity before writing the first prescription? This is the power of pharmacogenetic (PGx) testing. By analyzing key metabolic genes, primarily the Cytochrome P450 (CYP450) enzyme system, we can classify patients into distinct pheno

Read

Clinical Insight

Precision Over Guesswork: The Clinical Value of PGx Testing for Medication Matching

Introduction As a provider, you understand that every patient responds differently to treatment—especially when it comes to medications. Whether managing depression, anxiety, ADHD, chronic pain, or cardiovascular conditions, the challenge remains the same: finding the right medication at the right dose, without unnecessary trial and error. Pharmacogenetic (PGx) testing offers a clinically validated solution. By leveraging genetic insights, you can optimize prescribing decisions from the outset

Read

Clinical Insight

Leveraging ClarityX® Clinical Pharmacists for Confident Prescribing

Introduction Pharmacogenetic (PGx) testing delivers powerful insights—but interpreting those insights and translating them into patient care decisions can sometimes raise some questions, especially for providers new to PGx. At ClarityX®, we believe clinical support shouldn’t end when the report is delivered. That’s why every provider who orders a ClarityX® PGx test has access to our team of clinical pharmacists for result interpretation, education, and provider-to-provider consultation. In th

Read

Clinical Insight

ClarityX® vs. Insurance Labs: Choosing the Better Path for PGx Testing

Introduction When it comes to pharmacogenetic (PGx) testing, the provider’s intent is simple: identify the right medication for the patient based on their genetic profile. But the path to achieving that goal can vary dramatically depending on the lab you choose. If you’ve ever ordered a PGx test through an insurance-based lab, you may have encountered frustrating roadblocks—unclear billing, delayed results, incomplete reports, or denied coverage that surprises the patient after the fact. At C

Read

Clinical Insight

Identifying Ideal Candidates for Pharmacogenetic (PGx) Testing

Introduction: Pharmacogenetic (PGx) testing is a valuable clinical tool—but knowing when to use it and with whom is just as important as understanding how it works. Many providers recognize the benefits of personalized prescribing but aren’t always sure which patients will benefit most from PGx testing. This insight outlines practical, evidence-based criteria to help you identify strong candidates and incorporate PGx more proactively into clinical care. Why Timing and Patient Selection Matte

Read